Affordable Access

The use of aromatase inhibitors in in vitro fertilization

Authors
Journal
Fertility and Sterility
0015-0282
Publisher
Elsevier
Volume
98
Issue
6
Identifiers
DOI: 10.1016/j.fertnstert.2012.09.042
Disciplines
  • Biology

Abstract

The use of aromatase inhibitors (AIs) in IVF patients remains controversial. AIs can be considered for ovulation induction for IVF in women who are normal and poor responders, are at risk of ovarian hyperstimulation syndrome or thrombosis, who have endometriosis, and/or are undergoing fertility preservation procedures as a result of estrogen-dependent cancers, primarily breast and endometrial cancers. Although the biologic plausibility of the capacity of AIs in IVF patients is promising, results should be interpreted with caution, because the efficacy of AIs needs to be proven in randomized trials.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Inhibition of aromatase in vitro and in vivo by ar...

on Journal of enzyme inhibition 1990

[Use of aromatase inhibitors in infertile women].

on Gynécologie Obstétrique & Fert... October 2005

Aromatase inhibitors and their use in the adjuvant...

on Recent results in cancer resea... 1998

[Use of aromatase inhibitors in infertile women].

on Gynécologie Obstétrique & Fert... May 2005
More articles like this..